Nearly 90,000 bottles of children’s ibuprofen have been recalled over the potential presence of a foreign substance, according to the Food and Drug Administration.
Strides Pharma, Inc., headquartered in India, recalled about 89,592 bottles of its 100-milligram Children’s Ibuprofen Oral Suspension, the FDA said.
The affected product was manufactured for Taro Pharmaceuticals USA and distributed across the U.S.
The ibuprofen was sold in 4-fluid-ounce bottles at 100 milligrams per 5 milliliters.
HERBAL SUPPLEMENT FOUND TO CONTAIN HIDDEN VIAGRA INGEDIENT, FDA URGES CONSUMERS TO STOP USE
The packages included the lot numbers 7261973A and 7261974A with an expiration date of Jan. 31, 2027.
The recall was first issued earlier this month after complaints of a gel-like mass and black particles in the product.
GM RECALLS 17K VEHICLES OVER REAR TOE LINK FRACTURE THAT COULD LEAD TO CRASHES
But the FDA updated the classification this week to a Class II recall, which means “use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
The Class II classification is the FDA’s second-highest urgency level.
CLICK HERE TO GET FOX BUSINESS ON THE GO
Consumers who purchased the recalled ibuprofen are urged to stop using it immediately.
Parents with concerns after a child has consumed the product should consult a healthcare provider.
